Abstract

AimsWe assessed the performance of modelsf (risk scores) for predicting recurrence of atrial fibrillation (AF) in patients who have undergone catheter ablation.Methods and resultsSystematic searches of bibliographic databases were conducted (November 2018). Studies were eligible for inclusion if they reported the development, validation, or impact assessment of a model for predicting AF recurrence after ablation. Model performance (discrimination and calibration) measures were extracted. The Prediction Study Risk of Bias Assessment Tool (PROBAST) was used to assess risk of bias. Meta-analysis was not feasible due to clinical and methodological differences between studies, but c-statistics were presented in forest plots. Thirty-three studies developing or validating 13 models were included; eight studies compared two or more models. Common model variables were left atrial parameters, type of AF, and age. Model discriminatory ability was highly variable and no model had consistently poor or good performance. Most studies did not assess model calibration. The main risk of bias concern was the lack of internal validation which may have resulted in overly optimistic and/or biased model performance estimates. No model impact studies were identified.ConclusionOur systematic review suggests that clinical risk prediction of AF after ablation has potential, but there remains a need for robust evaluation of risk factors and development of risk scores.

Highlights

  • Atrial fibrillation (AF) is the most common arrhythmia diagnosed in clinical practice, and worldwide incidence and prevalence is increasing.[1]

  • Atrial fibrillation is associated with increased morbidity and mortality, cardiovascular related.[4,5]

  • We identified two systematic reviews on prognostic models for predicting recurrent AF after ablation[23,24]; these reviews had limited search strategies and did not include formal risk of bias appraisal

Read more

Summary

Introduction

Atrial fibrillation (AF) is the most common arrhythmia diagnosed in clinical practice, and worldwide incidence and prevalence is increasing.[1]. These patients remain at high risk of cardiovascular complications, often manifesting as heart failure or sudden death.[6,7] To mitigate this epidemic of AF-related disease, efforts are underway to improve primary and secondary prevention.[8,9]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.